Cập nhật 1/1Mới nhấtNgày thứ 2
FDA orders GLP-1 eye-risk warnings: what the numbers mean
The class-wide warning concerns rare, potentially permanent vision loss. The evidence warrants attention—not blanket advice to abandon treatment.
XemNguồn sớm nhấtU.S. Food and Drug Administration
Những gì chúng ta biết ban đầu
- 6.4Probable events per 100,000 person-years: GLP-1 treatment
- 3.8Probable events per 100,000 person-years: comparison treatment
- 15Probable events across both trial groups
